Delivery Order SPE2DB20D1100-SPE2DB25FE2J1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Prograf 5 mg capsules (100-count) with a contract ceiling value of $4,252.15. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is non-set-aside and was competitively awarded, reflecting AmerisourceBergen's established...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- This delivery order, awarded September 9, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 100 capsules of Prograf 1 mg, an immunosuppressant medication, with a ceiling value of $3,954.26 and completion date of September 10, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $106,966.00 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price, competitively awarded contract, with no set-aside designation, was finalized on September 22, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,167.21 to AmerisourceBergen Drug Corp for the supply of Prograf 0.5 mg capsules (100 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $1,051.74 to supply 100 capsules of the 0.5 mg Prograf medication. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 21, 2023. No set-aside designation was applied to this order, which was awarded against an existing indefinite-delivery contract held by Amerisourcebergen...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,657.94 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Prograf 1 mg capsules in quantities of 100 units. This contract is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without set-aside designation. The award represents a child contract under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,131.74 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $3,946.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the prescription medication Prograf in a 5 mg dosage. The delivery order was issued under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between July 13-14, 2023. No...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE2J1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,214.36 to AmerisourceBergen Drug Corp for 100 capsules of Prograf 1 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, reflecting the Defense Logistics Agency's commitment to supplying critical pharmaceuticals for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical prime vendor agreement running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp maintains extensive capacity to fulfill diverse pharmaceutical and medical supply needs across multiple therapeutic domains for military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 8/22/25 |